retinal atrophy as a biomarker in multiple sclerosis
Published 1 year ago • 151 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
2:28
assessing novel biomarkers: retinal layer atrophy in pms vs. rrms
-
2:14
prognostic biomarkers in multiple sclerosis
-
5:17
rates of neurodegeneration in the retina and cortex across the ms spectrum
-
1:59
using biomarkers to tailor treatment options for ms
-
3:47
the potential of retinal imaging for monitoring patients with ms
-
2:01
emerging biomarkers in ms: the value of serum nfl
-
1:12
microrna panel for multiple sclerosis: potential biomarkers?
-
4:19
skin innervation as a prognostic biomarker in als
-
2:11
emerging biomarkers of prognosis in ms
-
3:31
socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosis
-
3:19
retinal biomarkers in alzheimer’s disease
-
1:02
using the visual pathway to treat ms
-
1:53
oct-a: a diagnostic tool in multiple sclerosis
-
13:58
biomarkers for diagnosis and prognosis of ms
-
1:34
serum neurofilament levels are associated with health outcomes and resource use in ms
-
1:04
developing alzheimer’s disease biomarkers based on retinal imaging
-
2:51
no evidence of disease activity as a predictive measure of long-term disability in rrms
-
1:19
atrophy
-
2:49
project 1 - a novel imaging biomarker for retinal neurodegeneration